Last reviewed · How we verify

Salonpas — Competitive Intelligence Brief

Salonpas (METHYL SALICYLATE) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: methyl salicylate. Area: Immunology.

marketed methyl salicylate Immunology Small molecule Live · refreshed every 30 min

Target snapshot

Salonpas (METHYL SALICYLATE) — Hisamitsu Pharm Co.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Salonpas TARGET METHYL SALICYLATE Hisamitsu Pharm Co marketed methyl salicylate 2008-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

Sponsor landscape (methyl salicylate class)

  1. Hisamitsu Pharm Co · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Salonpas — Competitive Intelligence Brief. https://druglandscape.com/ci/methyl-salicylate. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: